| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.045 | 0.4 |